Watershed Therapeutics develops a novel, targeted drug-delivery platform for bladder diseases.
Watershed Therapeutics has raised $300K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2026.
Watershed Therapeutics's investors include Life Science Angels.
Watershed Therapeutics is headquartered in Los Altos, United States.
Watershed Therapeutics develops a novel, targeted drug-delivery platform for bladder diseases.
Watershed Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Watershed Therapeutics — Funding & Investors." VCBacked, April 13, 2026, https://www.vcbacked.co/company/watershed-therapeutics. Accessed August 16, 2026.
VCBacked. (2026). Watershed Therapeutics — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/watershed-therapeutics
{{cite web |title=Watershed Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/watershed-therapeutics |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated